Skip to main content
. 2013 Jun;81(6):1964–1973. doi: 10.1128/IAI.00059-13

Table 1.

Bacterial strains and plasmids used in this study

Strain or plasmid Relevant characteristicsa Source or reference
Strains
    G. anatis
        12656-12 Wild-type strain; biovar 4, isolated in 1981 (Denmark) 51
        ΔflfA mutant flfA deletion mutant of G. anatis 12656-12; Kmr This study
        F149T Wild-type strain; isolated in 1979 (Denmark) 2
        10672/6 Wild-type strain; biovar 1 (Denmark) 2
        4895 Wild-type strain; biovar 4 (Mexico) 52
        7990 Wild-type strain; biovar 1 (Mexico) 52
        Avicor Wild-type strain; biovar 3 (Mexico) 52
        CCM5995 Wild-type strain; biovar 20, isolated in 1978 (Czech Republic) 2
        IPDH 697-78 Wild-type strain; biovar 15, isolated in 1978 (Germany) 2
    E. coli
        TOP10 E. coli host strain for routine cloning Invitrogen
        DH5α E. coli host strain for routine cloning Invitrogen
        BL21 CodonPlus E. coli strain for expression of recombinant proteins Stratagene
Plasmids
    pENTR/SD/D-TOPO Directional cloning vector for entry to the Gateway System Invitrogen
    pDEST17 Gateway Destination vector (Ampr, N-terminal His6 fusion tag) Invitrogen
    pDEST17flfA FlfA expression vector (Ampr, N-terminal His6 fusion tag) This study
    pBluescript II KS(+) General purpose cloning vector (Ampr) Stratagene
    pUC4K Vector carrying the Kmr cassette from Tn903 53
    pBSΔflfA pBluescript II KS(+) containing flanking regions of the flfA gene (Ampr) This study
    pBSΔflfA-Kmr Plasmid for flfA deletion with flanking regions of the gene cloned on either side of the Kmr cassette from pUC4K into pBluescript II KS(+) (Ampr Kmr) This study
a

Ampr, ampicillin resistance; Kmr, kanamycin resistance; His, histidine.